Meng-ting Shen1, Zhi-gang Yang1, Kai-yue Diao1, Li Jiang1, Shan Huang1, Xiao-yue Zhou2, and Ying-kun Guo3
1Department of Radiology, West China Hospital, Sichuan University, Chengdu, China, 2MR Collaboration, Siemens Healthcare Ltd., Shanghai, China., Chengdu, China, 3West China Second University Hospital, Sichuan University, Chengdu, China
Synopsis
To explore prognostic role of clinical characteristics
and CMR based strains in ARVC patients. CMR was performed in 45 ARVC patients. LV
global strains in ARVC patients was significantly reduced than controls. Patients
with syncope had statistically lower LV global stains and greater LGE incidence
than without syncope. At 1037.51 ± 603.38 days mean follow-up, 14 patients
reached end point. By univariate and multivariate regression analysis, syncope
(OR= 48.66, [4.20-564.46]; P=0.002) and GLS> -12.72% (OR= 16.96, [1.79-160.66];
P=0.014) remained significantly associated with end point. Therefore, our study
found syncope and GLS> -12.72% could predict adverse events in patients with
ARVC
Purpose
To explore prognostic role of clinical characteristics
and cardiovascular magnetic resonance (CMR) based strain parameters in arrhythmogenic
right ventricular cardiomyopathy (ARVC) patients. Methods
CMR was performed in 45 ARVC patients and 34
healthy controls using a 3T MR scanner (MAGNETOM Skyra, Siemens Healthcare,
Erlangen, Germany). Feature-tracking analysis was applied to cine CMR images on
a commercial post-processing image station (Figure 1). Follow-up was performed at least 6-month intervals after
CMR scan. The outcome measure was a composite of end points: sudden cardiac
death, cardiac arrest, sustained ventricular tachyarrythmias, appropriate
implantable cardioverter defibrillator (ICD) shock and heart transplantation. Receiver-
operating characteristic (ROC) method was used to determine the optimal cut-off
values for the prediction of the endpointsResults
LV GLS (-14.17± 3.29% vs. -16.68 ± 2.74%), GCS
(-15.86 ± 3.52% vs. -19.20 ± 2.23%), GRS (35.14 ± 11.97% vs. 49.92 ± 12.59%) in
ARVC was significantly reduced in comparison with controls (P<0.001 for all)(Figure 2). Patients with syncope had
statistically lower LV GLS (-12.87 ± 3.09% vs. -14.60 ± 3.32%), GCS (-13.87 ±
3.09% vs. -16.34 ± 3.46%), GRS (28.22 ± 7.23% vs. 37.11 ± 23.38%) and greater LGE
incidence (70% vs. 40%) than that of patients without syncope (p<0.05 for
all)[1] (Figure 3). At
1037.51 ± 603.38 days mean follow-up, 14 patients reached the end point.
Patients GLS > -12.72% could predict outcome with a sensitivity of 77.42%
and specificity of 71.43%(AUC=0.759, p< 0.05)(Figure 4). By univariate analysis,
several clinical and CMR parameters including history of syncope, ICD, presence
of LGE and LV GLS> -12.72% were predictors of the endpoint. However,
multivariable analysis for the end point revealed only syncope (OR= 48.66, [4.20-564.46];
P=0.002) and GLS> -12.72% (OR= 16.96, [1.79-160.66]; P=0.014) as independent
predictors.(Figure 5)Discussion and Conclusions
CMR-based
Global strains of the left ventricle have shown to be reduced in ARVC patients[2],
which is less operator-dependent than visual wall motion analysis. After
following up 45 patients with ARVC for a median of 1037.51 days, we found syncope
and GLS> -12.72% could predict adverse events in patients with ARVC and
may help to optimize risk stratification in these patients[3].
Further, properly designed prospective studies are warranted to
confirm these findings.Acknowledgements
This work was
supported by the National Natural Science Foundation of China (81471721,
81471722, 81571668, 81771887, and 81771897)References
[1]: Cheng H, Lu M, Hou C, et. al
Comparative study of CMR characteristics between
arrhythmogenic right ventricular
cardiomyopathy patients with/without syncope.
Int J Cardiovasc Imaging. 2014
Oct;30(7):1365-72
[2]: Heermann P, Hedderich DM, Paul M, et.al.
Biventricular myocardial strain
analysis in patients with arrhythmogenic
right ventricular cardiomyopathy (ARVC)
using cardiovascular magnetic resonance
feature tracking. J Cardiovasc Magn
Reson. 2014 Oct 7;16:75
[3]: 2018 ESC Guidelines for the diagnosis
and management of syncope. Rev Esp
Cardiol (Engl Ed). 2018 Oct;71(10):837